Endothelial function and endothelial progenitor cells in systemic lupus erythematosus

Area of Science:

• Cardiovascular disease research
• Rheumatology
• Vascular biology

Background:

• Traditional cardiovascular disease (CVD) risk factors do not fully explain the elevated CVD mortality in systemic lupus erythematosus (SLE) patients.
• Endothelial dysfunction, an early stage of atherosclerosis, is a key area of investigation for CVD risk in SLE.
• Endothelial progenitor cells (EPCs) are vital for vascular repair and function but are reduced in number and impaired in function in SLE patients.

Purpose of the Study:

• To review the factors contributing to CVD in SLE.
• To focus on the evaluation and alterations of endothelial function and EPCs in SLE.
• To discuss the potential and limitations of using endothelial function and EPCs as prognostic markers for CVD in SLE.

Main Methods:

• Literature review of studies on CVD risk factors in SLE.
• Analysis of current methods for assessing endothelial function and EPCs.
• Examination of quantitative and functional changes in EPCs in SLE patients.

Main Results:

• Endothelial dysfunction is prevalent in SLE and contributes to CVD risk.
• EPCs are quantitatively and functionally deficient in SLE patients.
• Challenges exist in standardizing assessments of endothelial function and EPCs.

Conclusions:

• Endothelial dysfunction and altered EPCs are significant contributors to CVD in SLE.
• Standardized methods are required to translate endothelial function and EPC assessments into reliable prognostic markers for CVD in SLE.
• Further research is needed to overcome limitations in the current prognostication potential of these markers.